Literature DB >> 8045586

Induction of effective cross-reactive immunity by FMDV peptides is critically dependent upon specific MHC-peptide-T cell interactions.

E J Glass1, P Millar.   

Abstract

BoCD4+ T-cell clones specific for a peptide derived from foot-and-mouth disease virus envelope protein, VP1 (FMDV15) were generated from two responder cattle. One animal was a high and the other was an intermediate responder in terms of both T-cell and antibody responses. However both animals had identical major histocompatibility complex (MHC) class II DR-like types (DRBF3,6) according to a one-dimensional isoelectric focusing method which distinguishes DR-like alleles. In contrast, mixed lymphocyte reaction (MLR) responses indicated that they shared only one haplotype (DRBF3) and anti-DRBF6 alloclones also differentiated between the animals. This suggested that the animals differed at a non-DR-like locus. Restriction patterns of FMDV-specific clones derived from these animals indicated that FMDV15 was presented by the non-DR-like class II molecules associated with DRBF6. Only one clone, derived from the high responder animal, was restricted to DRBF3. Thus products from the non-DR-like locus (probably DQ-like) are functionally important for presentation of FMDV peptides. Furthermore the allelic differences detected by the alloclones are also critical for peptide binding. The majority of clones from the high responder animal recognized an immunodominant region containing a Rothbard epitope whereas none of the clones from the intermediate responder did so. This suggests that the region recognized by T cells, which is dependent upon MHC type, influences the B-cell response and thus the degree of protection obtained. This has major implications for rational vaccine design involving T- and B-cell epitopes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8045586      PMCID: PMC1414853     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  33 in total

1.  The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution.

Authors:  R Acharya; E Fry; D Stuart; G Fox; D Rowlands; F Brown
Journal:  Nature       Date:  1989-02-23       Impact factor: 49.962

2.  Protection of cattle against foot-and-mouth disease by a synthetic peptide.

Authors:  R DiMarchi; G Brooke; C Gale; V Cracknell; T Doel; N Mowat
Journal:  Science       Date:  1986-05-02       Impact factor: 47.728

3.  Characterization of a subset of bovine T lymphocytes that express BoT4 by monoclonal antibodies and function: similarity to lymphocytes defined by human T4 and murine L3T4.

Authors:  C L Baldwin; A J Teale; J G Naessens; B M Goddeeris; N D MacHugh; W I Morrison
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

4.  Biochemically defined polymorphism of bovine MHC class II antigens.

Authors:  I Joosten; M F Sanders; A van der Poel; J L Williams; B G Hepkema; E J Hensen
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

Review 5.  DNA and protein studies of HLA class II molecules: their relationship to T cell recognition.

Authors:  M Segall; J S Cairns; C A Dahl; J M Curtsinger; S Freeman; P J Nelson; O Cohen; S Wu; J N Nicklas; H J Noreen
Journal:  Immunol Rev       Date:  1985-07       Impact factor: 12.988

6.  Sequencing and genetic analysis of a bovine DQA cDNA clone.

Authors:  A Xu; K McKenna; H A Lewin
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

7.  Location and characterization of the antigenic portion of the FMDV immunizing protein.

Authors:  K Strohmaier; R Franze; K H Adam
Journal:  J Gen Virol       Date:  1982-04       Impact factor: 3.891

8.  Requirement for MHC class II positive accessory cells in an antigen specific bovine T cell response.

Authors:  E J Glass; R L Spooner
Journal:  Res Vet Sci       Date:  1989-03       Impact factor: 2.534

9.  A sequence pattern common to T cell epitopes.

Authors:  J B Rothbard; W R Taylor
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

10.  Limiting dilution comparison of the repertoires of high and low responder MHC-restricted T cells.

Authors:  M Kojima; K B Cease; G K Buckenmeyer; J A Berzofsky
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more
  6 in total

1.  Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus.

Authors:  E Blanco; M Garcia-Briones; A Sanz-Parra; P Gomes; E De Oliveira; M L Valero; D Andreu; V Ley; F Sobrino
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Foot-and-mouth disease virus exhibits an altered tropism in the presence of specific immunoglobulins, enabling productive infection and killing of dendritic cells.

Authors:  L Robinson; M Windsor; K McLaughlin; J Hope; T Jackson; B Charleston
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

3.  Quantitation of Anaplasma marginale major surface protein (MSP)1a and MSP2 epitope-specific CD4+ T lymphocytes using bovine DRB3*1101 and DRB3*1201 tetramers.

Authors:  Junzo Norimine; Sushan Han; Wendy C Brown
Journal:  Immunogenetics       Date:  2006-08-19       Impact factor: 2.846

4.  Functional expression of a cattle MHC class II DR-like antigen on mouse L cells.

Authors:  D C Fraser; S Craigmile; J D Campbell; R A Oliver; D J Brown; G C Russell; R L Spooner; E J Glass
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

5.  Selective lymphocyte depletion during the early stage of the immune response to foot-and-mouth disease virus infection in swine.

Authors:  Fayna Díaz-San Segundo; Francisco J Salguero; Ana de Avila; M Mar Fernández de Marco; Miguel A Sánchez-Martín; Noemí Sevilla
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

6.  Immunosuppression during acute infection with foot-and-mouth disease virus in swine is mediated by IL-10.

Authors:  Fayna Díaz-San Segundo; Teresa Rodríguez-Calvo; Ana de Avila; Noemí Sevilla
Journal:  PLoS One       Date:  2009-05-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.